Trial Profile
Vedolizumab in Patients with Moderate to Severe Ulcerative Colitis.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Dec 2009
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 26 Dec 2009 New trial record